June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Application of Widefield Swept-Source Optical Coherence Tomography Angiography in the Assessment of Retinal Microvasculature and Choroidal Thickness in Myopia Patients
Author Affiliations & Notes
  • Jade Moon
    Retina Service, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Itika Garg
    Retina Service, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Ying Cui
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Department of Ophthalmology, Guangdong Provincial People's Hospital, Guangzhou, Guangdong, China
  • Raviv Katz
    Retina Service, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Ying Zhu
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Department of Ophthalmology, Xiangya Hospital Central South University, Changsha, Hunan, China
  • Rongrong Le
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Department of Ophthalmology, Wenzhou Medical University, Wenzhou, Zhejiang, China
  • Yifan Lu
    Retina Service, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Edward S Lu
    Retina Service, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Cassie A. Ludwig
    Retina Service, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Tobias Elze
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • David M Wu
    Retina Service, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Joan W Miller
    Retina Service, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Leo A Kim
    Retina Service, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Deeba Husain
    Retina Service, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Demetrios G. Vavvas
    Retina Service, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • John Miller
    Retina Service, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Retinal Imaging Lab, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Jade Moon, None; Itika Garg, None; Ying Cui, None; Raviv Katz, None; Ying Zhu, None; Rongrong Le, None; Yifan Lu, None; Edward Lu, None; Cassie Ludwig, None; Tobias Elze, None; David Wu, Massachusetts Eye and Ear (P); Joan Miller, Genetech (C), Kalvista Pharmaceuticals (C), Sunovion (C), Valiant Pharmaceuticals/ Massachusetts Eye and Ear (P); Leo Kim, CureVac AG (F), National Eye Institute (F), Pykus Therapeutics (I); Deeba Husain, Allergan (C), Commonwealth Grant (F), Genetech (C), Lions VisionGift (F), Macular Society (F), OMEICOS Ophthalmics, Inc (C); Demetrios Vavvas, Alcon Research Institute (F), Loefflers Family Foundation (F), National Eye Institute (F), Olix Pharmaceuticals, Inc (C), Research to Prevent Blindness (F), Valitor, Inc (C), Yeatts Family Foundation (F); John Miller, Alcon (C), Allergan (C), Carl Zeiss Meditec, Inc (C), Genetech (C), Heidelberg Engineering, Inc (C)
  • Footnotes
    Support  Massachusetts Lions Eye Research Fund,Inc
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1940. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jade Moon, Itika Garg, Ying Cui, Raviv Katz, Ying Zhu, Rongrong Le, Yifan Lu, Edward S Lu, Cassie A. Ludwig, Tobias Elze, David M Wu, Joan W Miller, Leo A Kim, Deeba Husain, Demetrios G. Vavvas, John Miller; Application of Widefield Swept-Source Optical Coherence Tomography Angiography in the Assessment of Retinal Microvasculature and Choroidal Thickness in Myopia Patients. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1940.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In recent years, optical coherence tomography angiography (OCTA) has improved our understanding of microvascular changes in myopic macular degeneration. We performed a prospective cross-sectional study using widefield swept-source OCTA (WF SS-OCTA) to assess retinal microvasculature and choroidal thickness in myopia.

Methods : Patients with high myopia (HM; Spherical Equivalent (SE) ≤-6D or axial length ≥26.5mm), mild/moderate myopia (MM; -6D<SE≤-1D), and age-matched healthy subjects were imaged with PLEX Elite 9000 (Zeiss) using 3x3mm, 6x6mm, and 12x12mm scans centered on the fovea. Foveal Avascular Zone (FAZ) perimeter, area, and circularity, as well as vessel skeleton density (VSD), vessel density (VD), and choroidal thickness (CT) of entire retina, superficial, and deep slabs were analyzed using the ARI Network (Zeiss Portal).

Results : 186 eyes were analyzed; these eyes were categorized as 75 with HM, 43 with MM, and 68 age-matched controls. HM was associated with increased FAZ perimeter in 6x6 and 12x12 scans (P<.05, Table) and decreased circularity in all scans (P<.002, Table). HM and MM were associated with decreased VSD and VD in all slabs (P<.03, Table). Furthermore, HM was associated with a decrease in every ETDRS subfield, with a larger decrease temporally in 12x12 scans (βVSD=-13.21, βVD=-0.40, P<.001). HM was associated with decreased CT in all scan sizes (P<.03, Table). Changes in CT were unevenly distributed, with thinning most evident in the region between central fovea and optic disc and superior nasal subfields (P<.02, Figure C).

Conclusions : We identified decreased vessel density associated with myopia using WF SS-OCTA in a large, comprehensive cohort at a single center. We also observed regional differences including a greater decrease in VSD and VD in the temporal quadrant and uneven reductions in CT. Further work may help identify risk factors for the progression of pathologic myopia and other vision threatening complications.

This is a 2021 ARVO Annual Meeting abstract.

 

Table: Mixed effect multiple linear models results. β, regression coefficient.

Table: Mixed effect multiple linear models results. β, regression coefficient.

 

Figure: A-B. Boxplots of VSD and VD values in superficial (SF), deep (D), and retina (R) slabs. C. Regression coefficients of change in CT of HM by ETDRS subfield. Significant P-values (P<.05) are highlighted in darker color.

Figure: A-B. Boxplots of VSD and VD values in superficial (SF), deep (D), and retina (R) slabs. C. Regression coefficients of change in CT of HM by ETDRS subfield. Significant P-values (P<.05) are highlighted in darker color.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×